Macrogenics (MGNX) Change in Cash (2012 - 2026)
Macrogenics' (MGNX) quarterly Change in Cash came in at $9.3 million in Q1 2026, up 124.95% year-on-year from $4.1 million in Q1 2025, and up 140.59% on a QoQ basis from -$22.9 million in Q4 2025.
Macrogenics (MGNX) Change in Cash (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Change in Cash data on file, last reported at $9.3 million in Q1 2026.
- On a quarterly basis, Change in Cash rose 124.95% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was -$79.1 million, a 221.22% decrease from a year earlier, with the FY2025 full-year figure at -$125.6 million, down 253.42% from the prior year.
- Change in Cash for Q1 2026 stood at $9.3 million, up from -$22.9 million in the prior quarter.
- Over the last five years, Change in Cash for MGNX reached as high as $115.4 million in Q1 2023 and fell as low as -$115.5 million in Q2 2023.
- Historically, Change in Cash has averaged -$3.4 million across 5 years, with a median of -$14.9 million in 2025.
- Across the five-year window, Change in Cash soared 3905.38% in 2022 and plunged 812.66% in 2025, its largest moves.
- Year by year, Change in Cash stood at $24.9 million in 2022, then sank by 55.57% to $11.1 million in 2023, then plunged by 70.93% to $3.2 million in 2024, then plunged by 812.66% to -$22.9 million in 2025, then jumped by 140.59% to $9.3 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $9.3 million in Q1 2026, -$22.9 million in Q4 2025, and -$50.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.30 Mn |
| Dec 31, 2025 | -22.91 Mn |
| Sep 30, 2025 | -50.56 Mn |
| Jun 30, 2025 | -14.88 Mn |
| Mar 31, 2025 | -37.27 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 95.69 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | -20.60 Mn |
| Dec 31, 2023 | 11.06 Mn |
| Sep 30, 2023 | -18.86 Mn |
| Jun 30, 2023 | -115.51 Mn |
| Mar 31, 2023 | 115.38 Mn |
| Dec 31, 2022 | 24.89 Mn |
| Sep 30, 2022 | 62.52 Mn |
| Jun 30, 2022 | -25.86 Mn |
| Mar 31, 2022 | -76.14 Mn |
| Dec 31, 2021 | -67.06 Mn |
| Sep 30, 2021 | 1.56 Mn |
| Jun 30, 2021 | -29.53 Mn |